Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study

BACKGROUND: To compare the long-term efficacy of ranibizumab versus bevacizumab for myopic choroidal neovascularization (CNV). METHODS: This was a retrospective, multicenter, comparative, non-randomized study of 64 consecutive patients with myopic CNV treated with ranibizumab (22 patients) or bevaci...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Dong Min, Kim, Tae Wan, Heo, Jang Won, Woo, Se Joon, Park, Kyu Hyung, Yu, Hyeong Gon, Chung, Hum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042135/
https://www.ncbi.nlm.nih.gov/pubmed/24884970
http://dx.doi.org/10.1186/1471-2415-14-69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042135/
https://www.ncbi.nlm.nih.gov/pubmed/24884970
http://dx.doi.org/10.1186/1471-2415-14-69

Ejemplares similares